Schrödinger accelerates in silico discovery from plasmid to structure
Schrödinger uses the Sapio laboratory informatics platform to augment and extend its proprietary computational platform for in silico discovery of high-quality, novel molecules and to accelerate drug discovery efficiently.
Schrödinger, a global leader in computational chemistry, specializes in the discovery of high-quality, novel molecules for materials science and drug development through its proprietary physics-based platform. Schrödinger implemented the Sapio Platform, incorporating Sapio LIMS and Sapio ELN to digitize and streamline operations within its newly established wet lab.
